LWBP
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 5
About LWBP
, trading as LWBP specializes in oncology drug development. LWBP specializes in developing innovative pharmaceuticals that address unmet clinical needs, with a focus on autoimmune diseases, tumor immunotherapy, and antiviral therapies. Its core product, LW231, is a Class 1 new drug designed for the complete cure of hepatitis B and is currently in Phase Ib/II clinical trials. LWBP engages in medical translation and commercialization through partnerships and licensing agreements, extending its market reach beyond China. Revenue generation is structured through partnerships and licensing agreements with pharmaceutical companies and healthcare providers, facilitating direct procurement of treatments by healthcare institutions. The company aims to provide competitive and affordable solutions for a broad market segment.
Who invested in LWBP
5 investors across 1 round
See all investors in LWBP
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 27, 2025
Amount
Undisclosed
Investors
Questions about LWBP
Who invested in LWBP?
LWBP has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LWBP raised?
LWBP has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LWBP last raise money?
LWBP's most recent round on record is a Series B, in Oct 2025.
What does LWBP do?
, trading as LWBP specializes in oncology drug development.
Where is LWBP headquartered?
LWBP is headquartered in Shanghai, China.
Which VCs invest in companies like LWBP?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back companies at LWBP's stage. Their profiles are linked below.
VCs to look at next
Raising like LWBP? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.